Pharmaceuticals companies seems to have started rebuilding their advertising expenditure as evident in the latest reports that suggests advertising expenditure of pharmaceutical companies increased by 9 percent in the first half of this year. The advertising expenditure of this sector was sluggish aftyer the landmark withdrawal of the pain killer medicine Vioxx in the year 2004.
According to the reports, ad expenditure rose to $2.46 billion in the first half of the current year. The maximum chunk of the expenditure was consumed by Magazines, as the majority of campaigns focus on promoting their images and disease awareness. According to TNS Media intelligence, in the corresponding period last year the ad expenditure was to a large extent remained flat at $2.26 billion.
After the Vioxx debacle, the pharmaceutical companies are now following a cautious approach and have formed voluntary guidelines to improve and maintain accuracy and balance of the advertisements.
Read
